Regular biography
Dr. David M. Perrin is a distinguished researcher in the field of chemical biology, with a particular focus on the development of radiolabeled compounds for biomedical imaging, especially in the context of positron emission tomography (PET). His work has significantly advanced the field of radiopharmaceutical chemistry, particularly in the area of one-step, aqueous 18F-labeling of peptides and small molecules for in vivo imaging applications. Dr. Perrin's research has been instrumental in creating efficient and scalable methods for the synthesis of radiolabeled compounds, which are critical for the diagnosis and treatment of various diseases, including cancer. His contributions have been widely recognized through numerous publications in high-impact journals and presentations at major scientific conferences. Dr. Perrin's work not only bridges the gap between chemical synthesis and biological imaging but also has practical implications for the development of new diagnostic tools and therapeutic strategies.